Latest posts
-
Selank: Research on the Tuftsin-Based Anxiolytic Peptide and Its GABAergic and Neurotrophin Mechanisms
Selank is a synthetic heptapeptide derived from tuftsin, registered in Russia as an anxiolytic and adaptogen. Its proposed mechanisms include GABAergic modulation, enkephalin stabilization, and BDNF upregulation. This research overview covers its structural origin, preclinical findings in anxiety models, and clinical registration data from Russian trials.
-
Semax: Research on the ACTH-Derived Neuropeptide and Its Nootropic and Neuroprotective Profile
Semax is a synthetic heptapeptide derived from the ACTH(4-7) sequence, developed in Russia and registered there for acute ischemic stroke and cognitive applications. This research overview covers its BDNF/NGF-upregulating mechanism, preclinical findings in cognitive and neuroprotection models, and its clinical registration history in Russia.
-
SS-31: Mitochondria-Targeted Peptide Research and What the Data Show About Cardiolipin and Cellular Energy
SS-31 (Elamipretide) is a mitochondria-targeted tetrapeptide designed to protect cardiolipin — a critical inner mitochondrial membrane phospholipid — from oxidative damage. This research overview covers its unique design rationale, cardiolipin-based mechanism, preclinical findings across cardiac and renal models, and human clinical trial data in heart failure and Barth syndrome.
-
Thymosin Alpha-1: The Immune-Modulating Peptide with Decades of Published Clinical Research
Thymosin alpha-1 is a naturally occurring 28-amino acid peptide from thymic tissue with one of the most extensive published clinical research histories among investigational peptides. This article covers its immune-modulating mechanisms, published trial data in viral hepatitis, sepsis, and cancer immunotherapy, and its complex international regulatory landscape.
-
LL-37: Research on the Human Cathelicidin Antimicrobial Peptide and Its Immunomodulatory Biology
LL-37 is the only known human cathelicidin — an antimicrobial peptide central to innate immunity, with documented roles in wound healing, immunomodulation, angiogenesis, and skin disease biology. This research overview covers its natural biology, antimicrobial mechanism, immunomodulatory functions, and its complex role in skin conditions including rosacea and psoriasis.
-
KPV: Research on the Alpha-MSH Tripeptide and Its Anti-Inflammatory Mechanisms
KPV is a tripeptide (lysine-proline-valine) derived from the C-terminal region of alpha-melanocyte-stimulating hormone. Research has focused on its anti-inflammatory properties, particularly in intestinal inflammation models, where its apparent activity at the gut mucosa through PepT1-mediated transport has generated interest in oral delivery applications for IBD research.
-
Cognitive Peptides: Semax, Selank, and the Neuropeptide Research Landscape
Semax, Selank, and DSIP represent three distinct neuropeptide research profiles — BDNF modulation, GABAergic anxiolysis, and sleep architecture — developed over decades of Russian and international research. This overview examines mechanisms, research limitations, and methodological considerations. For research use only.
-
Context Before Conclusions: How to Read Peptide Research Headlines
Most peptide headlines ask “did it work?” That’s the wrong first question. Here’s what context you actually need before drawing conclusions from peptide research.
-
Interest Is Not Evidence: Separating Peptide Popularity from Clinical Proof
Just because a peptide dominates longevity podcasts doesn’t mean the clinical evidence is there. Learn to separate peptide popularity from actual clinical proof.
-
FDA Updates Are Business Signals for Clinics and Med Spas
In the peptide space, regulatory changes move faster than clinic websites. Here’s why FDA updates are business intelligence—not compliance footnotes—for clinics and med spas.
